Apyx Medical (APYX) Receivables - Net (2016 - 2025)
Apyx Medical (APYX) has disclosed Receivables - Net for 16 consecutive years, with $16.8 million as the latest value for Q4 2025.
- For the quarter ending Q4 2025, Receivables - Net rose 8.37% year-over-year to $16.8 million, compared with a TTM value of $16.8 million through Dec 2025, up 8.37%, and an annual FY2025 reading of $16.8 million, up 8.37% over the prior year.
- Receivables - Net was $16.8 million for Q4 2025 at Apyx Medical, up from $13.0 million in the prior quarter.
- Across five years, Receivables - Net topped out at $16.8 million in Q4 2025 and bottomed at $7.7 million in Q1 2021.
- Average Receivables - Net over 5 years is $11.9 million, with a median of $12.2 million recorded in 2022.
- The sharpest move saw Receivables - Net soared 85.96% in 2021, then decreased 20.53% in 2022.
- Year by year, Receivables - Net stood at $13.0 million in 2021, then dropped by 18.68% to $10.6 million in 2022, then surged by 32.27% to $14.0 million in 2023, then rose by 10.39% to $15.5 million in 2024, then increased by 8.37% to $16.8 million in 2025.
- Business Quant data shows Receivables - Net for APYX at $16.8 million in Q4 2025, $13.0 million in Q3 2025, and $11.2 million in Q2 2025.